Jan 6, 2026 05:05AM GH Research (GHRS) Reiterated at Market Outperform by Citizens on GH001 Potential

Jan 5, 2026 11:52AM TD Cowen on GH Research PLC (GHRS): 'Today's update...was very cleane'

Jan 5, 2026 09:59AM Guggenheim Reiterates Buy Rating on GH Research PLC (GHRS) Post Mgmt Call

Jan 5, 2026 07:34AM Stifel Reiterates Buy Rating on GH Research PLC (GHRS)

Jan 2, 2026 04:19PM GH Research soars on planned FDA update on depression drug candidate

Jan 2, 2026 04:01PM GH Research to update IND status for depression treatment on Jan 5

Nov 6, 2025 07:17AM GH Research PLC (GHRS) Tops Q3 EPS by 1c

Oct 13, 2025 06:00AM Needham Starts GH Research PLC (GHRS) at Buy

Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'

Sep 10, 2025 06:50AM Cantor Fitzgerald Reiterates Overweight Rating on GH Research PLC (GHRS)

Aug 7, 2025 10:21AM Stifel Reiterates Buy Rating on GH Research PLC (GHRS)

Aug 7, 2025 09:44AM GH Research PLC (GHRS) Tops Q2 EPS by 6c

Jul 25, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on GH Research PLC (GHRS)

Jul 24, 2025 04:38AM Citizens JMP Reiterates Market Outperform Rating on GH Research PLC (GHRS)

Jul 23, 2025 08:02AM GH Research reports 73% remission rate in depression trial data

Jul 10, 2025 06:45AM Canaccord Genuity Reiterates Buy Rating on GH Research PLC (GHRS)

Jun 24, 2025 04:04AM Citizens JMP Reiterates Market Outperform Rating on GH Research PLC (GHRS)

Jun 20, 2025 01:01PM GH Research (GHRS) Submits Complete IND Hold Response to FDA Ahead of Schedule

Jun 4, 2025 07:42AM Cantor Fitzgerald Assumes GH Research PLC (GHRS) at Overweight, ' Smoking the Toad - A Big Wave of Psychedelics Is Coming'

May 8, 2025 05:18PM GH Research PLC (GHRS) Tops Q1 EPS by 16c

Mar 5, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on GH Research PLC (GHRS)

Feb 26, 2025 04:16PM GH Research PLC (GHRS) PT Raised to $32 at Stifel

Feb 13, 2025 06:32AM Cantor Fitzgerald Starts GH Research PLC (GHRS) at Overweight

Feb 4, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on GH Research PLC (GHRS)

Feb 3, 2025 04:03PM GH Research (GHRS) Announces Proposed Public Offering

Feb 3, 2025 03:20PM GH Research PLC (GHRS) PT Raised to $42 at Rodman & Renshaw

Feb 3, 2025 07:00AM GH Research (GHRS) Announces Primary Endpoint Met in Phase 2b Trial with GH001

Jan 31, 2025 04:02PM GH Research (GHRS) to Provide Update on Phase 2b Trial with GH001 in TRD

Jan 27, 2025 07:22AM H.C. Wainwright Reiterates Buy Rating on GH Research PLC (GHRS)

Jan 10, 2025 07:07AM GH Research (GHRS) Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents

Nov 20, 2024 07:25AM H.C. Wainwright Reiterates Buy Rating on GH Research PLC (GHRS)

Nov 18, 2024 07:12AM GH Research PLC (GHRS) PT Lowered to $28 at Canaccord Genuity

Nov 14, 2024 07:02AM GH Research PLC (GHRS) Tops Q3 EPS by 1c

Sep 6, 2024 06:54AM H.C. Wainwright Reiterates Buy Rating on GH Research PLC (GHRS)

Sep 3, 2024 07:02AM GH Research (GHRS) Appoints Villy Valcheva as CEO